Evidence map›Paper›PMID 35252724›Full record

ArticleACS omega2022

Buried-Gate MWCNT FET-Based Nanobiosensing Device for Real-Time Detection of CRP.

Ali Firoozbakhtian, Ali Hossein Rezayan, Hassan Hajghassem, Fereshteh Rahimi, Masoud Faraghi Ghazani, Mahsa Kalantar, Amir Mohamadsharifi

Abstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ali FiroozbakhtianDivision of Nanobiotechnology, Department of Life Sciences Engineering, Faculty of New Sciences and Technologies, University of Tehran, P.O. Box 14395-1561 Tehran 1439957131, Iran.ORCID https://orcid.org/0000-0002-3024-5258
Ali Hossein RezayanDivision of Nanobiotechnology, Department of Life Sciences Engineering, Faculty of New Sciences and Technologies, University of Tehran, P.O. Box 14395-1561 Tehran 1439957131, Iran.ORCID https://orcid.org/0000-0003-0414-0062
Hassan HajghassemMEMS & NEMS Laboratory, Faculty of New Sciences & Technologies, University of Tehran, Tehran 1439957131, Iran.
Fereshteh RahimiDivision of Nanobiotechnology, Department of Life Sciences Engineering, Faculty of New Sciences and Technologies, University of Tehran, P.O. Box 14395-1561 Tehran 1439957131, Iran.
Masoud Faraghi GhazaniMEMS & NEMS Laboratory, Faculty of New Sciences & Technologies, University of Tehran, Tehran 1439957131, Iran.
Mahsa KalantarDivision of Nanobiotechnology, Department of Life Sciences Engineering, Faculty of New Sciences and Technologies, University of Tehran, P.O. Box 14395-1561 Tehran 1439957131, Iran.
Amir MohamadsharifiMEMS & NEMS Laboratory, Faculty of New Sciences & Technologies, University of Tehran, Tehran 1439957131, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

C-reactive protein (CRP), an acute-phase protein synthesized in the liver in response to inflammation, is one of the biomarkers used for the detection of several diseases. Sepsis and cardiovascular diseases are two of the most important diseases for which detection of CRP at very early stages in the clinical range can help avert serious consequences. Here, a CNT-based nanobiosensing system, which is portable and reproducible, is used for label-free, online detection of CRP. The system consists of an aptameric CNT-based field-effect transistor benefiting from a buried gate geometry with Al

Identifiers

PMID35252724
PMCPMC8892644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.